08045800513
Send Inquiry
Send InquirySodium Valproate & Valproic Acid
MOQ : 15-30 Boxes
Sodium Valproate & Valproic Acid Specification
- Drug Type
- Specific Drug
- Ingredients
- Alprazolam 0.25 mg & Fluoxetine 20 mg
- Physical Form
- Tablets
- Function
- Other
Sodium Valproate & Valproic Acid Trade Information
- Minimum Order Quantity
- 15-30 Boxes
- Payment Terms
- Cheque, Western Union, Paypal, Cash in Advance (CID), Cash Advance (CA)
- Sample Policy
- Sample costs shipping and taxes has to be paid by the buyer
- Packaging Details
- Alu-Alu,10*10 tablet Packing
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Sodium Valproate & Valproic Acid
Sodium Valproate & Valproic Acid tablets, available in sustained-release forms (200 SR, 300 SR, and 500 SR), are specifically formulated to provide optimal therapeutic effects for adults and aged individuals. Designed to manage various neurological and psychiatric conditions, these tablets combine Sodium Valproate and Valproic Acid in precise ratios for efficient drug release and sustained action. Kaypon 200 SR contains 133 mg of Sodium Valproate and 58 mg of Valproic Acid, while Kaypon 300 SR contains 200 mg of Sodium Valproate and 87 mg of Valproic Acid. For higher doses, Kaypon 500 SR delivers 333 mg of Sodium Valproate combined with 145 mg of Valproic Acid. Manufactured in tablet form, these drugs are exported, supplied, and produced to meet stringent quality standards, ensuring safety and efficacy for patients. Their sustained-release formulation helps maintain therapeutic drug levels, reducing dosing frequency and improving patient compliance.
FAQs of Sodium Valproate & Valproic Acid:
Q: What is the purpose of Sodium Valproate & Valproic Acid tablets?
A: These tablets are used to manage neurological and psychiatric conditions, such as epilepsy, bipolar disorder, and migraines.Q: What are the dosage variants available?
A: Dosage variants include 200 SR, 300 SR, and 500 SR, with specific combinations of Sodium Valproate and Valproic Acid.Q: Who are these tablets suitable for?
A: These tablets are suitable for adults and elderly individuals.Q: What are the benefits of sustained-release tablets?
A: Sustained-release tablets ensure consistent therapeutic drug levels, reduce dosing frequency, and improve compliance.Q: How are these tablets supplied?
A: They are supplied by exporters, manufacturers, and suppliers adhering to high-quality standards.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti-Psychotic And Anti-Depressants Category
Fluoxetine 20 mg
Minimum Order Quantity : 1530 Boxes
Function : Other
Ingredients : Alprazolam 0.25 mg & Fluoxetine 20 mg
Drug Type : Other, Prescription drug
Recommended For : Adults and children above 8 years (as directed by physician)
Physical Form : Tablets
Divalproex Sodium 250 mg & 500 mg (Sustained Release)
Minimum Order Quantity : 1530 Boxes
Function : Other
Ingredients : Alprazolam 0.25 mg & Fluoxetine 20 mg
Drug Type : Specific Drug
Recommended For : Epilepsy, Migraine, Mania
Physical Form : Tablets
Risperidone 1 mg & 3 mg
Minimum Order Quantity : 1530 Boxes
Function : Other
Ingredients : Alprazolam 0.25 mg & Fluoxetine 20 mg
Drug Type : Specific Drug
Recommended For : Schizophrenia,Acute manic episodes of bipolar disorders,Irritability assoc.with autistic disorder
Physical Form : Tablets
Duloxetine 20 mg & 40 mg
Minimum Order Quantity : 1530 Boxes
Function : Other
Ingredients : Alprazolam 0.25 mg & Fluoxetine 20 mg
Drug Type : Specific Drug
Recommended For : moderate to severe Stress Urinary Incontinence( SUI)
Physical Form : Tablets
Contact Details
- Plot No. 73, Industrial Area, Phase-2,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
